Synthetic gene delivery vectors offer potential advantages over viral vectors for systemic administration. Ease of vector production, customization through conjugation of additional enhancement ...
Vector BioPharma AG (Vector BioPharma), a biopharmaceutical company aiming to transform the safety, efficacy, and specificity of drug delivery to improve treatments for patients, today announced that ...
Versant launched the biotech out of its Ridgeline Discovery Engine in Basel, Switzerland. (Nuthawut Somsuk/Getty Images) Versant Ventures has committed $30 million to improve gene delivery. By pumping ...
Adeno-associated viral vectors are highly safe and efficient gene delivery vehicles. However, numerous challenges in vector design remain, including neutralizing antibody responses, tissue transport ...